Pfizer has awarded the $60-80 million Lipitor ad account to The Kaplan Thaler Group in New York.
KTG already handles Celebrex for Pfizer.
The losers in the review were JWT and mcgarrybowen. Merkley + Partners, who used to do the Lipitor ads, were not included in the review for the cholesterol and heart disease therapy.
Pfizer is currently recycling old Lipitor ads.
No comments:
Post a Comment